← FDA DRUG APPROVALS

FDA ANDA · ANDA040590

CAFERGOT

ergotamine tartrate and caffeine

Sponsor: MIKART

APPLICATION
ANDA040590
TYPE
ANDA
ORIGINAL APPROVAL
2005-09-16
LATEST ACTION
2024-06-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ERGOTAMINE TARTRATE AND CAFFEINEPrescription
CAFFEINE 100MG, ERGOTAMINE TARTRATE 1MG · TABLET · ORAL

Approval history

2024-06-14Labeling · Supplement 9 · standardAP
2024-06-14Labeling · Supplement 5 · standardAP
2005-09-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →